Publication
Peginterferon alfa-2a (40KD) plus 800 or 1000/1200 mg/day ribavirin in genotype 1 HIV–HCV co-infected patients: early responses to treatment and predictability for SVR in the PARADIGM study
| dc.contributor.author | Rodriguez-Torres, M | |
| dc.contributor.author | Slim, J | |
| dc.contributor.author | Bhatti, L | |
| dc.contributor.author | Sterling, R | |
| dc.contributor.author | Hassanein, T | |
| dc.contributor.author | Clotet, B | |
| dc.contributor.author | Branco, T | |
| dc.contributor.author | Bertasso, A | |
| dc.contributor.author | Stancic, S | |
| dc.contributor.author | Sulkowski, M | |
| dc.date.accessioned | 2011-03-10T11:55:59Z | |
| dc.date.available | 2011-03-10T11:55:59Z | |
| dc.date.issued | 2010 | |
| dc.identifier.citation | In: INTERNATIONAL LIVER CONGRESS. Annual Meeting of the European Association for the Study of the Liver, 45, Vienna, 14-18 April, 2010 | por |
| dc.identifier.uri | http://hdl.handle.net/10400.10/304 | |
| dc.language.iso | other | por |
| dc.language.iso | por | |
| dc.peerreviewed | yes | por |
| dc.publisher | European Association for the Study of the Liver | por |
| dc.subject | Peginterferão alfa-2a | por |
| dc.subject | Peginterferon alfa-2a | por |
| dc.subject | Ribavirina | por |
| dc.subject | Ribavirin | por |
| dc.subject | Infecção por HIV | por |
| dc.subject | HIV infections | por |
| dc.subject | Hepatite C | por |
| dc.subject | Hepatitis C | por |
| dc.subject | PARADIGM study | por |
| dc.title | Peginterferon alfa-2a (40KD) plus 800 or 1000/1200 mg/day ribavirin in genotype 1 HIV–HCV co-infected patients: early responses to treatment and predictability for SVR in the PARADIGM study | por |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Vienna | por |
| oaire.citation.title | INTERNATIONAL LIVER CONGRESS. Annual Meeting of the European Association for the Study of the Liver, 45 | por |
| rcaap.rights | openAccess | por |
| rcaap.type | conferenceObject | por |